Poland· PL-100499920
Fruzaqla
A fruquintinib product containing fruquintinibum, registered in Poland by Takeda Pharmaceuticals International AG Ireland Branch. The same ATC class is registered in 16 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Fruquintinib is registered in 16 of 19 countries.
Countries holding a registration under ATC L01EK04 (fruquintinib), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 10 of them publish a price we can compare per daily dose
Fruquintinib · ATC L01EK04
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of fruquintinib costs, country by country.
Normalised to the WHO defined daily dose (3.75 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Fruquintinib · price per daily dose (3.75 mg)
USD · FX 28 Sept 2026
- CH Switzerland$189.98
The record
At a glance
URPL (Poland)- Active substance
- Fruquintinibum
- Manufacturer
- Takeda Pharmaceuticals International AG Ireland Branch
- Country
- Poland (PL)
- ATC code
- L01EK04
- ATC class
- Fruquintinib
- Defined daily dose
- 3.75 mg, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 2
- gtin04150193460436
- gtin07038319163867
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Fruquintinib in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesFruzaqlaTakeda Pharmaceuticals America, Inc.
- CanadaFRUZAQLATAKEDA CANADA INC
- SwitzerlandFruzaqla
- CzechiaFRUZAQLATakeda Pharmaceuticals International AG Ireland Branch, Dublin
- SpainFRUZAQLA 1 MG CAPSULAS DURASTakeda Pharmaceuticals International Ag Ireland Branch
- FinlandFRUZAQLATakeda Pharmaceuticals International AG Ireland Branch
- FranceFRUZAQLA 1 mg, géluleTAKEDA PHARMACEUTICALS INTERNATIONAL (IRLANDE)
- BelgiumFruzaqla 1 mgTakeda Pharmaceuticals International Ireland Branch
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Fruzaqla
- Liechtenstein · Fruzaqla
- Norway · Fruzaqla
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/cbf317e4-54b3-48e7-b493-82405fa5a45c GET /v1/drugs/cbf317e4-54b3-48e7-b493-82405fa5a45c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Kapsułki twarde",
"source": "urpl",
"strength": "1 mg",
"packaging": "07038319163867 ¦ Rpz ¦ EU/1/24/1827/001 ¦ 157073\n1 butelka 21 kaps.\n¦ UR/Z/4c/164/24 - 04150193460436",
"substance": "Fruquintinibum 1 mg",
"common_name": "Fruquintinibum",
"pl_product_id": "100499920",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about fruquintinib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.